Table S2
This helps lower blood sugar without typically causing hypoglycemia, which is why GLP-1 therapy can be used in both diabetic and some non-diabetic patients
A licensed provider reviews your intake and writes a prescription if appropriate
For patients with high risk of developing NAION (eg, those with diabetes or hypertension) who are taking GLP-1 receptor agonists, ophthalmologists may increase vigilance. The researchers concluded that further research is warranted to replicate these findings, explore underlying mechanisms, identify individuals at increased risk for these potential complications and examine other eye disorders. Diabetic retinopathy In another analysis, David J
Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, Gagnier J, Borenstein M, van der Heijden G, Dahabreh IJ, et al
Researchers value it because it triggers growth hormone release while keeping cortisol and prolactin levels stable